PLEASE JOIN GYNUITY HEALTH PROJECTS
at the
XXII FIGO WORLD CONGRESS OF GYNECOLOGY AND OBSTETRICS
October 14 -19, 2018 │ Riocentro │ Rio de Janeiro, Brazil
|
|
Gynuity Health Projects is again delighted to be part of the FIGO World Congress. We invite you to join us for an exciting program featuring highlights from our global research and collaborative projects on reproductive and maternal health. If you are attending the Congress, we look forward to seeing you at these sessions:
|
|
Sunday, October 14, 2018
9:00 – 15:00 Room 201 a&b
|
|
Pre-congress Workshop: Abortion Technology
Training in first and second trimester uterine evacuation techniques for induced abortion, pregnancy loss and fetal demise. Open to new and experienced providers. Workshop outline available
here
.
Organizers
National Abortion Federation; Gynuity Health Projects; Fundación Oriéntame; BPAS; Ipas; DKT; Marie Stopes Mexico; Global Doctors for Choice
|
|
Monday, October 15, 2018
Station 2
|
|
Poster
Beyond blood loss: Role of shock index in the diagnosis of postpartum hemorhage
Jill Durocher
|
|
Monday, October 15, 2018
14:30 - 16:00
FCS 8.171 Stage 2
|
|
Free Communication/Clinical Obstetrics
Characterizing Misoprostol’s Thermoregulatory Effects When Used to Treat Postpartum Hemorrhage
Jesús Daniel Aguirre
|
|
Monday, October 15, 2018
16:30 - 17:30
FCS14.182 Stage 2
|
|
Free Communication/ Clinical Obstetrics
Core Outcome Sets for Prevention and Treatment of PPH: An International Delphi Consensus Study
Jennifer Blum
|
|
Tuesday, October 16, 2018
8:30 - 10:00
FCS20.191 Stage 2
|
|
Free Communication/Clinical Obstetrics
Does Route Matter? Intravenous Versus Intramuscular Oxytocin for Prevention of Postpartum Hemorrhage
Beverly Winikoff
|
|
Tuesday, October 16, 2018
14:30 – 16:00 Room 202a
Organizers
Gynuity & FIGO
Moderator
Beverly Winikoff
|
|
New Thinking and Innovations in the Management of Postpartum Hemorrhage
T
ime to rethink how we diagnose PPH? What new research tells us about the potential role of shock index in PPH diagnosis
Rodolfo Pacagnella
University of Campinas
The side effects, safety and effectiveness of misoprostol and tranexamic acid in the first line treatment of PPH
Jill Durocher
The safety and effectiveness of introducing uterine balloon tamponade for PPH management: A stepped wedge, cluster randomized trial in Egypt, Senegal and Uganda
Holly Anger
No magic bullet: Key lessons learned from global research to introduce new technologies for PPH management
Rasha Dabash
|
|
Wednesday, October 17, 2018
8:30 – 10:00 Room 202a
Organizers
Gynuity
Moderator
Paul Blumenthal
|
|
New Frontiers in Abortion Care: Translating the Latest Evidence on Medical Abortion Innovations into Simpler More Accessible Services
Simplifying and expanding access to outpatient medical abortion: New evidence in settings with and without access to mifepristone
Rasha Dabash
Management of pregnancy failure: New evidence and clinical updates
Hillary Bracken
New evidence to support changes in policy, practice and access to medical abortion for women with gestations greater than 13 weeks
Jennifer Blum
Telemedicine delivery of medical abortion: Evidence from the TelAbortion project in the U.S.
Beverly Winikoff
|
|
Wednesday, October 17, 2018
10:30 – 12:00 Room 202c
Organizers/Moderators
Nathalie Kapp, Ipas & Rasha Dabash, Gynuity
|
|
Challenging Cases in Care for Termination of Pregnancy
Case presentation followed by discussion with:
Olímpio Moraes
(Brazil),
Laura Gil
(Colombia),
Claudia Martinez López
(Mexico),
Françoise Hougni
(France), &
Sharmin Sultana
(Bangladesh)
|
|
Wednesday, October 17, 2018 16:00 - 17:30
FCS 63.314 Stage 3
|
|
Free Communication/Clinical Obstetrics
Stillbirth, Co-Morbidities and Multi-Causality in Maternal Deaths with Obstetric Hemorrhage in Uganda
Holly Anger
|
|
Thursday, October 18, 2018
10:30 - 12:00
FCS 74.338 Stage 2
|
|
Free Communication/Clinical Obstetrics
Understanding the Consequences of Overuse of Uterotonics in Low- and Middle-Income Settings
Rasha Dabash
|
|
Thursday, October 18, 2018
14:30 – 16:00 Room 205
Moderators
Miguel Mancera & Fanny Corrales
This session will be in Spanish
|
|
Salud de la Mujer en América Latina y el Caribe
Women's Health in Latin America and Caribbean
Dimensiones éticas y legales de la confidencialidad en la prestación de servicios de salud reproductiva / Ethical and legal dimensions of confidentiality in the delivery of reproductive health services
Pío Ivan Gómez
Las obligaciones profesionales en el consultorio y los servicios de salud sexual / Professional obligations in the office and sexual health services
Leonel Briozzo
Una revisión del régimen legal de indicaciones para el aborto en América Latina y de su implementación / A review of the legal regime of indications for abortion in Latin America and its implementation
Raffaela Schiavon
La distribución de misoprostol para el manejo de la HPP en base a la experiencia global / Advance distribution of misoprostol for PPH management based on global experience
Jill Durocher
|
|
Thursday, October 18, 2018
16:00 – 17:30 Room 210
Organizers
Abortion & Postabortion Care Consortium
Moderator
Kathryn Mimno, Pathfinder
|
|
De-Medicalizing Abortion and Postabortion Care to Expand Access in the Public and Private Sector in Both Restrictive and Less Restrictive Settings
Global evidence and lessons learned on de-medicalization of abortion and postabortion care
Rasha Dabash
Women’s needs, wants and autonomy in accessing safe abortion and postabortion care
Patty Skuster
Ipas
The role of the private sector in abortion and postabortion care
Dhammika Perera
Marie Stopes International
|
|
Thursday, October 18, 2018
16:00 – 17:30 Room 202a
Organizers
PRE-EMPT
Moderators
Peter Von Dadelszen
& Laura Magee
|
|
PRE-EMPT (Preeclampsia–Eclampsia Monitoring, Prevention & Treatment): The Findings
PRE-EMPT Overview
Peter Von Dadelszen
CAP Trial: Does calcium inter- and early-pregnancy replacement (500mg/d) prevent recurrent pre-eclampsia?
Justus Hofmeyr
PIERS scores and mhealth apps: Time-of-disease risk estimation
Beth Payne
Oral Antihypertensive Therapy Trial: Comparing the efficacy of oral labetalol, nifedipine & methyldopa in the management of severe pregnancy hypertension
Hillary Bracken & Shuchita Mundle
CLIP Trials: India, Pakistan & Mozambique
Laura Magee, Mrutunjaya Bellad, Rahat Qureshi & Esperança Sevene
|
|
|
|
|
|
|
